Solid technology, smart decisions at the heart of Regeneron's remarkable R&D productivity
16 July 2014
Regeneron Pharmaceuticals has emerged as one of the most prolific wellsprings of new antibody drugs in the biopharma universe thanks to its success in combining innovative technologies with intelligent target selection.
Russian patients will be available to innovative treatments for skin cancer
15 July 2014
In recent years, the world is rapidly increasing incidence of cancer including skin cancer, which accounted for Russia in the structure of malignant tumors account for 10.7% and each year this figure grows by 2-3%. This arises primarily environmental degradation and the harmful effects of ultraviolet radiation from the sun, having a carcinogenic effect.
Bullish On Russian Pharmaceutical Market Despite Risks
15 July 2014
Demographic trends, rising incomes and greater state spending on healthcare will drive growth within the Russian pharmaceutical sector. However, we also see risks to investment and considerable barriers for foreign companies. On balance, we remain bullish on the growth prospects for Russian pharmaceutical spending, but highlight local companies as having better opportunities to realise this growth than multinationals.
Russia may have its own curing HIV vaccine in 3-4 years
15 July 2014
Russia is expecting to have its own therapeutic vaccine to fight HIV in three-to-four years, following a series of clinical trials. Andrei Kozlov of the Federal Medical and Biological Agency, an official overseeing the vaccine project, shared the news with the Russian news agency RIA Novosti.
New type of surgical complex being developed in Russia
15 July 2014
NPTs Biotechnology, a spin-off of Russia’s Institute of Design and Technology Informatics, is working on what is believed to be a next-generation robotic complex for surgeries, the Skolkovo Foundation website reported .
RF prime minister to present government awards to young scientists
09 July 2014
Russia’s Prime Minister Dmitry Medvedev on Monday will present RF government awards for 2013 in the sphere of science and technology to young scientists.
Russia may have its own curing HIV vaccine in 3-4 years
08 July 2014
Russia is expecting to have its own therapeutic vaccine to fight HIV in three-to-four years, following a series of clinical trials. Andrei Kozlov of the Federal Medical and Biological Agency, an official overseeing the vaccine project, shared the news with the Russian news agency RIA Novosti.
A Russian venture capital firm closed $200M to invest in Europe (including healthcare)
08 July 2014
Runa Capital, a Moscow-based global tech-focused venture capital firm, announced yesterday the first closing of its new fund, Runa Capital II. With a target size of $200 million, the firm will continue investing in tech-based companies worldwide, focusing especially on Europe. The amount of the first closing has not been disclosed.
National Bioscience Report Reveals Positive Trends for Bioscience Industry
01 July 2014
A recent study analyzing the US bioscience industry growth over the past 11 years, through the recent recession and early economic recovery, reveals positive trends. The industry demonstrated a strong record of growth from 2001-2012.
More than 430 New Medicines in Development for Chronic Diseases
01 July 2014
According to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA), America’s biopharmaceutical research companies are developing 435 new medicines to target 15 leading chronic conditions affecting the Medicare population. These medicines in development include: 110 for diabetes, 62 for rheumatoid arthritis and osteoarthritis, 67 for Alzheimer’s disease, 61 for heart disease (i.e., heart failure, hypertension, ischemic heart disease and high cholesterol), and 40 for chronic obstructive pulmonary disease (COPD).
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
The first Russian device for testing TB is registered
14 January 2025
Russians spend 1.6 trillion rubles on medications in 2024
14 January 2025
2024 drug approvals: Small companies loom large with several key FDA nods
13 January 2025
Special Regulations for Foreign-Packaged Medicines Extended Until the End of 2025
13 January 2025